Symbols / TNON $0.79 +0.56%
TNON Chart
About
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 8.80M |
| Enterprise Value | 6.63M | Income | -12.81M | Sales | 3.23M |
| Book/sh | 0.20 | Cash/sh | 0.40 | Dividend Yield | — |
| Payout | 0.00% | Employees | 27 | IPO | — |
| P/E | 0.14 | Forward P/E | -0.81 | PEG | — |
| P/S | 2.72 | P/B | 3.96 | P/C | — |
| EV/EBITDA | -0.55 | EV/Sales | 2.05 | Quick Ratio | 1.56 |
| Current Ratio | 2.15 | Debt/Eq | 4.50 | LT Debt/Eq | — |
| EPS (ttm) | 5.86 | EPS next Y | -0.97 | EPS Growth | — |
| Revenue Growth | 32.20% | Earnings | 2026-03-19 | ROA | -65.80% |
| ROE | -197.26% | ROIC | — | Gross Margin | 52.40% |
| Oper. Margin | -222.76% | Profit Margin | 0.00% | Shs Outstand | 11.11M |
| Shs Float | 7.72M | Short Float | 7.53% | Short Ratio | 0.34 |
| Short Interest | — | 52W High | 5.85 | 52W Low | 0.64 |
| Beta | 1.25 | Avg Volume | 1.03M | Volume | 62.15K |
| Target Price | $2.75 | Recom | None | Prev Close | $0.79 |
| Price | $0.79 | Change | 0.56% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$2.75
Mean price target
2. Current target
$0.79
Latest analyst target
3. DCF / Fair value
$-11.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.79
Low
$2.50
High
$3.00
Mean
$2.75
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-04-09 | init | Alliance Global Partners | — → Buy | $3 |
| 2024-11-15 | main | Maxim Group | Buy → Buy | $8 |
| 2024-08-14 | reit | Benchmark | Speculative Buy → Speculative Buy | $3 |
| 2024-04-15 | main | Benchmark | Speculative Buy → Speculative Buy | $3 |
- Back pain device maker stacks up 29 US patents, 31 more applications pending - Stock Titan Wed, 18 Feb 2026 08
- Tenon Medical CEO Foster buys $25k in TNON stock and warrants - Investing.com ue, 18 Nov 2025 08
- Tenon Medical Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks Fri, 27 Feb 2026 08
- Sacro-pelvic care company Tenon nearly doubles Q4 2025 revenue - Stock Titan Wed, 28 Jan 2026 08
- Tenon Medical Inc. Stock Surge: What’s Behind It? - StocksToTrade Fri, 01 Aug 2025 07
- Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing - Yahoo Finance Fri, 14 Nov 2025 08
- Tenon Medical Announces 1:8 Reverse Split - ACCESS Newswire Fri, 25 Apr 2025 11
- Curious about the stocks that are showing activity after the closing bell on Friday? - ChartMill Fri, 06 Feb 2026 08
- Tenon Medical (TNON): chief commercial officer Grawey buys shares - Investing.com ue, 18 Nov 2025 08
- Aug Rallies: Is TNON a momentum stock - Trade Exit Summary & Long Hold Capital Preservation Plans - baoquankhu1.vn hu, 05 Mar 2026 09
- Tenon Medical Reaffirms Strong 2025 Revenue Growth Outlook - TipRanks Fri, 06 Feb 2026 08
- 12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga Mon, 09 Feb 2026 08
- Tenon Medical (TNON) Q2 2025 Earnings Transcript - AOL.com Wed, 13 Aug 2025 07
- Tenon Medical reaffirms Q4 revenue up ~90% YoY, FY ~20% - Stock Titan hu, 05 Feb 2026 08
- Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance ue, 25 Mar 2025 07
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1041 | — | — | WILLIAMSON KEVIN | Chief Financial Officer | — | 2026-03-03 00:00:00 | D | nan |
| 1 | 64478 | — | — | FERRARI RICHARD M | Director | — | 2025-12-31 00:00:00 | D | nan |
| 2 | 10732 | — | — | WEIGLE ROBERT K. | Director | — | 2025-12-31 00:00:00 | D | nan |
| 3 | 10732 | — | — | HOCHSCHULER STEPHEN H | Director | — | 2025-12-31 00:00:00 | D | nan |
| 4 | 140936 | — | — | FOSTER STEVEN M | Chief Executive Officer | — | 2025-12-31 00:00:00 | D | nan |
| 5 | 10732 | — | — | HOWARD IVAN | Director | — | 2025-12-31 00:00:00 | D | nan |
| 6 | 126577 | — | — | GINN RICHARD | Chief Technology Officer | — | 2025-12-31 00:00:00 | D | nan |
| 7 | 10729 | — | — | JACQUES KRISTINE M | Director | — | 2025-12-31 00:00:00 | D | nan |
| 8 | 58987 | — | — | WILLIAMSON KEVIN | Chief Financial Officer | — | 2025-12-31 00:00:00 | D | nan |
| 9 | 19455 | — | Purchase at price 1.18 per share. | FOSTER STEVEN M | Chief Executive Officer | — | 2025-11-14 00:00:00 | D | 22957.0 |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -13.17M | -15.30M | -18.45M | -6.35M |
| TotalUnusualItems | 183.00K | 167.00K | 180.00K | 2.00K |
| TotalUnusualItemsExcludingGoodwill | 183.00K | 167.00K | 180.00K | 2.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -13.67M | -15.58M | -18.92M | -7.05M |
| ReconciledDepreciation | 655.00K | 426.00K | 289.00K | 114.00K |
| ReconciledCostOfRevenue | 1.57M | 1.69M | 1.33M | 55.00K |
| EBITDA | -12.98M | -15.13M | -18.27M | -6.35M |
| EBIT | -13.64M | -15.56M | -18.56M | -6.46M |
| NetInterestIncome | -34.00K | -21.00K | -354.00K | -621.00K |
| InterestExpense | 34.00K | 21.00K | 354.00K | 621.00K |
| NormalizedIncome | -13.86M | -15.75M | -19.10M | -7.05M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -13.67M | -15.58M | -18.92M | -7.05M |
| TotalExpenses | 17.04M | 18.66M | 19.42M | 6.62M |
| TotalOperatingIncomeAsReported | -13.77M | -15.73M | -18.73M | -6.46M |
| DilutedAverageShares | 1.21M | 226.75K | 100.12K | 140.46K |
| BasicAverageShares | 1.21M | 226.75K | 100.12K | 140.46K |
| DilutedEPS | -11.26 | -68.72 | -188.96 | -50.18 |
| BasicEPS | -11.26 | -68.72 | -188.96 | -50.18 |
| DilutedNIAvailtoComStockholders | -13.67M | -15.58M | -18.92M | -7.05M |
| NetIncomeCommonStockholders | -13.67M | -15.58M | -18.92M | -7.05M |
| NetIncome | -13.67M | -15.58M | -18.92M | -7.05M |
| MinorityInterests | 0.00 | 33.00K | ||
| NetIncomeIncludingNoncontrollingInterests | -13.67M | -15.58M | -18.92M | -7.08M |
| NetIncomeContinuousOperations | -13.67M | -15.58M | -18.92M | -7.08M |
| PretaxIncome | -13.67M | -15.58M | -18.92M | -7.08M |
| OtherIncomeExpense | 127.00K | 167.00K | 162.00K | 1.00K |
| OtherNonOperatingIncomeExpenses | -56.00K | -18.00K | -1.00K | |
| GainOnSaleOfSecurity | 183.00K | 167.00K | 180.00K | 2.00K |
| NetNonOperatingInterestIncomeExpense | -34.00K | -21.00K | -354.00K | -621.00K |
| InterestExpenseNonOperating | 34.00K | 21.00K | 354.00K | 621.00K |
| OperatingIncome | -13.77M | -15.73M | -18.73M | -6.46M |
| OperatingExpense | 15.48M | 16.97M | 18.08M | 6.57M |
| ResearchAndDevelopment | 2.60M | 3.16M | 2.83M | 1.72M |
| SellingGeneralAndAdministration | 12.87M | 13.80M | 15.26M | 4.85M |
| SellingAndMarketingExpense | 5.11M | 6.78M | 7.83M | 2.14M |
| GeneralAndAdministrativeExpense | 7.76M | 7.03M | 7.42M | 2.71M |
| OtherGandA | 7.76M | 7.03M | 7.42M | 2.71M |
| GrossProfit | 1.71M | 1.24M | -641.00K | 105.00K |
| CostOfRevenue | 1.57M | 1.69M | 1.33M | 55.00K |
| TotalRevenue | 3.28M | 2.93M | 691.00K | 160.00K |
| OperatingRevenue | 3.28M | 2.93M | 691.00K | 160.00K |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 3.14M | 325.04K | 140.46K | 140.46K |
| ShareIssued | 3.14M | 325.04K | 140.46K | 140.46K |
| NetDebt | 10.59M | |||
| TotalDebt | 428.00K | 1.86M | 911.00K | 14.62M |
| TangibleBookValue | 2.22M | 778.00K | 6.25M | -20.55M |
| InvestedCapital | 2.22M | 1.95M | 6.25M | -7.05M |
| WorkingCapital | 6.34M | 749.00K | 6.82M | -7.60M |
| NetTangibleAssets | 5.97M | 778.00K | 6.25M | -20.55M |
| CapitalLeaseObligations | 428.00K | 684.00K | 911.00K | 1.11M |
| CommonStockEquity | 2.22M | 778.00K | 6.25M | -20.55M |
| PreferredStockEquity | 3.75M | |||
| TotalCapitalization | 5.97M | 778.00K | 6.25M | -20.55M |
| TotalEquityGrossMinorityInterest | 5.97M | 778.00K | 6.25M | -20.55M |
| MinorityInterest | 0.00 | 0.00 | ||
| StockholdersEquity | 5.97M | 778.00K | 6.25M | -20.55M |
| GainsLossesNotAffectingRetainedEarnings | 0.00 | -46.00K | -100.00K | -91.00K |
| OtherEquityAdjustments | -46.00K | -100.00K | -91.00K | |
| RetainedEarnings | -68.75M | -55.07M | -39.49M | -20.57M |
| AdditionalPaidInCapital | 70.96M | 55.90M | 45.84M | 113.00K |
| CapitalStock | 3.75M | 0.00 | 1.00K | 1.00K |
| CommonStock | 3.00K | 0.00 | 1.00K | 1.00K |
| PreferredStock | 3.75M | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 3.87M | 5.57M | 4.84M | 29.82M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 2.00M | 2.43M | 2.31M | 14.55M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 13.64M | ||
| NonCurrentAccruedExpenses | 1.86M | 2.00M | 1.62M | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 141.00K | 428.00K | 683.00K | 911.00K |
| LongTermCapitalLeaseObligation | 141.00K | 428.00K | 683.00K | 911.00K |
| CurrentLiabilities | 1.87M | 3.14M | 2.53M | 15.27M |
| CurrentDebtAndCapitalLeaseObligation | 287.00K | 1.43M | 228.00K | 13.71M |
| CurrentCapitalLeaseObligation | 287.00K | 256.00K | 228.00K | 202.00K |
| CurrentDebt | 1.17M | 13.51M | ||
| OtherCurrentBorrowings | 1.17M | 13.51M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 416.00K | 334.00K | 452.00K | 846.00K |
| PayablesAndAccruedExpenses | 1.17M | 1.38M | 1.85M | 720.00K |
| CurrentAccruedExpenses | 797.00K | 944.00K | 1.30M | 242.00K |
| Payables | 369.00K | 433.00K | 550.00K | 478.00K |
| AccountsPayable | 369.00K | 433.00K | 550.00K | 478.00K |
| TotalAssets | 9.84M | 6.34M | 11.09M | 9.27M |
| TotalNonCurrentAssets | 1.63M | 2.46M | 1.74M | 1.60M |
| NonCurrentPrepaidAssets | 51.00K | 51.00K | 51.00K | 41.00K |
| NonCurrentDeferredAssets | 431.00K | 798.00K | 25.00K | 374.00K |
| NetPPE | 1.15M | 1.61M | 1.67M | 1.19M |
| AccumulatedDepreciation | -668.00K | -273.00K | -80.00K | -2.00K |
| GrossPPE | 1.82M | 1.88M | 1.75M | 1.19M |
| Leases | 15.00K | 15.00K | 0.00 | |
| ConstructionInProgress | 541.00K | 602.00K | 601.00K | 0.00 |
| OtherProperties | 1.20M | 1.20M | 1.08M | 1.16M |
| MachineryFurnitureEquipment | 65.00K | 65.00K | 65.00K | 26.00K |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 8.21M | 3.89M | 9.35M | 7.67M |
| OtherCurrentAssets | 206.00K | 389.00K | ||
| PrepaidAssets | 389.00K | 134.00K | 87.00K | |
| Inventory | 606.00K | 554.00K | 415.00K | 188.00K |
| FinishedGoods | 585.00K | 532.00K | 406.00K | 173.00K |
| RawMaterials | 21.00K | 22.00K | 9.00K | 15.00K |
| Receivables | 863.00K | 518.00K | 228.00K | 76.00K |
| AccountsReceivable | 863.00K | 518.00K | 228.00K | 76.00K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | 0.00 | 0.00 | |
| GrossAccountsReceivable | 518.00K | 228.00K | 76.00K | |
| CashCashEquivalentsAndShortTermInvestments | 6.54M | 2.43M | 8.57M | 7.32M |
| OtherShortTermInvestments | 0.00 | 6.44M | 4.40M | |
| CashAndCashEquivalents | 6.54M | 2.43M | 2.13M | 2.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -10.06M | -12.54M | -12.87M | -4.39M |
| RepaymentOfDebt | 0.00 | -245.00K | ||
| IssuanceOfDebt | 0.00 | 1.25M | 0.00 | 12.07M |
| IssuanceOfCapitalStock | 9.76M | 5.30M | 14.14M | 0.00 |
| CapitalExpenditure | -186.00K | -361.00K | -847.00K | -102.00K |
| InterestPaidSupplementalData | 0.00 | 0.00 | 1.00K | |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 1.00K | |
| EndCashPosition | 6.54M | 2.43M | 2.13M | 2.92M |
| BeginningCashPosition | 2.43M | 2.13M | 2.92M | 246.00K |
| EffectOfExchangeRateChanges | 46.00K | 38.00K | 7.00K | -2.00K |
| ChangesInCash | 4.06M | 261.00K | -795.00K | 2.67M |
| FinancingCashFlow | 14.12M | 6.30M | 14.11M | 11.47M |
| CashFlowFromContinuingFinancingActivities | 14.12M | 6.30M | 14.11M | 11.47M |
| NetOtherFinancingCharges | -1.10M | -509.00K | -25.00K | -358.00K |
| ProceedsFromStockOptionExercised | 5.46M | 258.00K | 0.00 | |
| NetPreferredStockIssuance | 3.15M | 0.00 | ||
| PreferredStockIssuance | 3.15M | 0.00 | ||
| NetCommonStockIssuance | 6.61M | 5.30M | 14.14M | 0.00 |
| CommonStockIssuance | 6.61M | 5.30M | 14.14M | 0.00 |
| NetIssuancePaymentsOfDebt | 0.00 | 1.25M | 0.00 | 11.83M |
| NetShortTermDebtIssuance | 0.00 | 1.25M | 0.00 | |
| ShortTermDebtIssuance | 0.00 | 1.25M | 0.00 | |
| NetLongTermDebtIssuance | 0.00 | 11.83M | ||
| LongTermDebtPayments | 0.00 | -245.00K | ||
| LongTermDebtIssuance | 0.00 | 12.07M | ||
| InvestingCashFlow | -186.00K | 6.14M | -2.88M | -4.50M |
| CashFlowFromContinuingInvestingActivities | -186.00K | 6.14M | -2.88M | -4.50M |
| NetInvestmentPurchaseAndSale | 0.00 | 6.50M | -2.04M | -4.40M |
| SaleOfInvestment | 0.00 | 7.00M | 8.08M | 0.00 |
| PurchaseOfInvestment | 0.00 | -493.00K | -10.12M | -4.40M |
| NetPPEPurchaseAndSale | -186.00K | -361.00K | -847.00K | -102.00K |
| PurchaseOfPPE | -186.00K | -361.00K | -847.00K | -102.00K |
| OperatingCashFlow | -9.88M | -12.18M | -12.03M | -4.29M |
| CashFlowFromContinuingOperatingActivities | -9.88M | -12.18M | -12.03M | -4.29M |
| ChangeInWorkingCapital | -746.00K | -1.17M | 1.72M | 452.00K |
| ChangeInOtherCurrentLiabilities | -256.00K | -227.00K | -202.00K | -82.00K |
| ChangeInPayablesAndAccruedExpense | -235.00K | -216.00K | 2.36M | 870.00K |
| ChangeInAccruedExpense | -171.00K | -99.00K | 2.29M | 426.00K |
| ChangeInPayable | -64.00K | -117.00K | 72.00K | 444.00K |
| ChangeInAccountPayable | -64.00K | -117.00K | 72.00K | 444.00K |
| ChangeInPrepaidAssets | 183.00K | -301.00K | -57.00K | -130.00K |
| ChangeInInventory | -52.00K | -139.00K | -227.00K | -145.00K |
| ChangeInReceivables | -386.00K | -290.00K | -152.00K | -61.00K |
| ChangesInAccountReceivables | -386.00K | -290.00K | -152.00K | -61.00K |
| OtherNonCashItems | 1.92M | 1.85M | ||
| StockBasedCompensation | 3.85M | 4.14M | 2.90M | 377.00K |
| UnrealizedGainLossOnInvestmentSecurities | 0.00 | -16.00K | -2.00K | |
| ProvisionandWriteOffofAssets | 41.00K | 0.00 | ||
| AssetImpairmentCharge | 0.00 | 77.00K | 0.00 | |
| DepreciationAmortizationDepletion | 655.00K | 426.00K | 289.00K | 114.00K |
| DepreciationAndAmortization | 655.00K | 426.00K | 289.00K | 114.00K |
| Depreciation | 655.00K | 426.00K | 289.00K | 114.00K |
| OperatingGainsLosses | -2.03K | |||
| GainLossOnInvestmentSecurities | -2.03K | |||
| NetIncomeFromContinuingOperations | -13.67M | -15.58M | -18.92M | -7.08M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for TNON
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|